✦ LIBER ✦

O6 SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION IS SAFE AND EFFECTIVE IN DIFFICULT-TO-TREAT POPULATIONS INCLUDING GENOTYPE-3 PATIENTS, DECOMPENSATED GENOTYPE-1 PATIENTS, AND GENOTYPE-1 PATIENTS WITH PRIOR SOFOSBUVIR TREATMENT EXPERIENCE

✍ Scribed by Gane, E.J.; Hyland, R.H.; An, D.; Pang, P.S.; Symonds, W.T.; Mchutchison, J.G.; Stedman, C.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

238 Sofosbuvir/Ledipasvir Fixed Dose Com

✍ Gane, Edward; Hyland, Rob H.; Pang, Phil; Symonds, William T.; McHutchison, John 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 703 KB

O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHO

✍ Kowdley, K.V.; Stuart, G.C.; Reddy, R.K.; Rossaro, L.; Bernstein, D.E.; An, D.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 172 KB

O164 ALL ORAL FIXED-DOSE COMBINATION SOF

✍ Mangia, A.; Marcellin, P.; Kwo, P.; Foster, G.R.; Buti, M.; Bräu, N.; Muir, A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Sofosbuvir and ledipasvir fixed-dose com

✍ Lawitz, Eric; Poordad, Fred F; Pang, Phillip S; Hyland, Robert H; Ding, Xiao; Mo 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 400 KB

O109 ALL ORAL FIXED-DOSE COMBINATION SOF

✍ Afdhal, N.; Reddy, R.K.; Pockros, P.; Di Bisceglie, A.M.; Arora, S.; Yang, J.C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 151 KB